On April 12, 2023 CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, reported that the management team will participate in two upcoming investor conferences in April 2023 (Press release, CTI BioPharma, APR 12, 2023, View Source [SID1234629990]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

22nd Annual Needham Virtual Healthcare Conference
Type: Fireside Chat
Tuesday, April 18, 2023
3:45 p.m. ET (12:45 p.m. PT)

Stifel 2023 Targeted Oncology Days (Virtual)
Type: Corporate Presentation
Wednesday, April 26, 2023
1:00 p.m. ET (10:00 a.m. PT)

A link to the live and archived webcast may be accessed on the CTI BioPharma website under the Investors & Media section: Events and Presentations.